Constant M. Verschuur
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Long-Term Follow-Up of the LEAP Study: Early Versus Delayed Levodopa in Early Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 02, 2023
Changes in neurologists' treatment preferences for Parkinson's disease in the Netherlands.
Journal: Clinical parkinsonism & related disorders
Published: July 12, 2023
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson's Disease.
Journal: Journal of Parkinson's disease
Published: August 08, 2022
Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP Study.
Journal: Neurology
Published: December 29, 2021
Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD).
Journal: Journal of Parkinson's disease
Published: June 30, 2020
Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.
Journal: The New England journal of medicine
Published: January 24, 2019
Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study.
Journal: BMC neurology
Published: October 28, 2015
Anti-aquaporin 4 related paraneoplastic neuromyelitis optica in the presence of adenocarcinoma of the lung.
Journal: Clinical neuropathology
Published: May 27, 2015
Serotonin transporter availability in early stage Parkinson's disease and multiple system atrophy.
Journal: ISRN neurology
Published: November 07, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026